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INTERVIEW WITH DR. WEIYAN JIAN  
简伟研博士访谈 
 
By Jing Li 
李婧 
 
Dr. Weiyan Jian is an associate professor in the Department of Health Policy and Administration at 
School of Public Health, Peking University. He is the Principle Investigator of the CMB Open 
Competition-awarded research proposal titled “Evaluating the impacts of DRGs Payment Reform in 
Beijing”. 
简伟研博士是北京大学公共卫生学院卫生政策与管理学系副教授。他领导的研究项目“北京病组支付方式效果
评估”为 CMB 公开竞标获奖项目。 
 
Jing Li is a doctoral student in the Health Economics Track of Health Services and Policy Analysis 
program at University of California, Berkeley. 
李婧为加州伯克利大学卫生服务与政策分析专业卫生经济方向博士生。 
 
Jing: What are the most important considerations in the choice of research topic? 
李婧：您此次选择研究课题时最重要的考虑是什么？ 
 
Dr. JIAN: There are two considerations in the choice of research topic: one is research interest, and 
the other is the need to address or provide scientific evidence for certain practical issues in 




Jing: What are the main obstacles in hospital data access and usage? Do you have any 




Dr. JIAN: Hospitals submit reports as part of the health statistics system required by the Ministry of 
Health. The “discharge form” (the front page of a medical record) is at the patient-level and is 
similar to the discharge data in the United States. This is the main data source for our DRG 
research. There is significant cost involved in negotiating with multiple hospitals in accessing the 
data, and support from administrative departments is often needed in the process. There are 
several limitations in the discharge form data. First, the data only contain variables on medical 
treatments and expenditures, but no patient socio-demographics. Second, there is significant 
variation across hospitals not only in data quality but also in diagnosis and procedure coding 
systems, except in certain areas (e.g. Beijing). These are issues that need particular attention 
when we are using the discharge data. 
简伟研：从常规数据来看，医院层面的报表主要是卫生部要求上报的“卫统”系列报告，其中“出院病人调查








Jing: How do you think the research results will affect health policy and systems sciences in China? 
李婧: 您认为研究结果对于中国卫生政策和系统科学有何影响？ 
 
Dr. JIAN: Provider payment reform is a hot topic in China’s current health reform, and Beijing is the 
first city in China that adopted hospital DRG payment in a systematic way. Our research could 
not only help Beijing improve the local health policy, but also provide evidence for policymakers 
in other areas contemplating DRG payment reform. Moreover, there are many debates 
internationally regarding the benefit of DRG payment, and our research may be able to inform 






Jing: What is your most important learning experience from the CMB OC grant application? How it 




Dr. JIAN: CMB’s Open Competition has provided an opportunity for young scholars in China to 
compete for research funding as well as the freedom to select research topics based on our 
own interests. CMB has also organized a strong panel of external reviewers who provided 
applicants with excellent critique and advice. All of these would not only benefit the OC 
applicants but also provide additional resources that promote open competition among young 
scholars in China’s HPSS field. I would like to express my sincere gratitude towards CMB and all 
external reviewers who contributed to OC! 
简伟研：CMB-OC 项目为中国的年轻学者提供了公平竞争获取研究资助的机会，让大家可以根据自己的研究
兴趣自由选择研究题目。CMB 组织了强大的外部评审专家团队，为参评的学者提出了很好的意见和建议。
所有这些，不仅有益于 OC 项目的申请者本人，更重要的是，在中国 HPSS 领域形成了另一个可以让年轻
学者公开竞标的研究支持资源。衷心感谢 CMB 和所有为 OC 做出贡献的外部评审专家！ 
  
